Efficacy of Human Placental Graft in Diabetic Foot Ulcers

NCT03708029 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2024-07-01

No results posted yet for this study

Summary

To determine the efficacy of full-thickness placental allograft in chronic wound healing

Conditions

  • Diabetic Foot

Interventions

OTHER

Revita Allograft

Human placental allograft

Sponsors & Collaborators

  • StimLabs

    lead INDUSTRY

Principal Investigators

  • Clinical Research Manager · StimLabs

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-13
Primary Completion
2019-12-01
Completion
2019-12-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03708029 on ClinicalTrials.gov